AIC
MYOV

Archer Investment Corporation’s Myovant Sciences Ltd. MYOV Stock Holding History

Archer Investment Corporation’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$2.76K – 777
2020
Q4 		$2.76K Buy
+100
New +$1.95K ﹤0.01% 618

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Archer Investment Corporation's MYOV Position: Q1 2021 in Review

Archer Investment Corporation sold out of Myovant Sciences Ltd. (MYOV) in Q1 2021, closing a stake of 100 shares — an estimated $2.76K sold.

Archer Investment Corporation first reported a position in MYOV in Q4 2020 and held it in 1 quarter. The position peaked at $2.76K in Q4 2020. 104 funds tracked by Wall St. Rank hold MYOV as of Q1 2021.

  • Archer Investment Corporation reported no remaining Myovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Archer Investment Corporation sold 100 Myovant Sciences Ltd. shares in Q1 2021, an estimated $2.76K.
  • Archer Investment Corporation first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Archer Investment Corporation's Myovant Sciences Ltd. position peaked at $2.76K in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2021.

Based on Archer Investment Corporation's 13F filing for Q1 2021, filed 14 May 2021.